Publicaciones en las que colabora con María Sagrario Bustabad Reyes (16)

2024

  1. Real-world persistence of initial targeted therapy strategy in monotherapy versus combination therapy in patients with chronic inflammatory arthritis

    European Journal of Clinical Investigation, Vol. 54, Núm. 2

2022

  1. Prevalence of symptomatic axial osteoarthritis phenotypes in Spain and associated socio-demographic, anthropometric, and lifestyle variables

    Rheumatology International, Vol. 42, Núm. 6, pp. 1085-1096

  2. Prévalence de la goutte dans la population générale en Espagne : une estimation du taux de cas non diagnostiqués

    Revue du Rhumatisme (Edition Francaise), Vol. 89, Núm. 4, pp. 389-395

  3. The reality of Rheumatology in Spain and its autonomous communities before the pandemic

    Reumatologia Clinica, Vol. 18, Núm. 8, pp. 486-489

2021

  1. Comment on: Prevalence of systemic lupus erythematosus in Spain: higher than previously reported in other countries? Reply

    Rheumatology (Oxford, England), Vol. 60, Núm. 3, pp. e120-e121

  2. Prevalence of symptomatic osteoarthritis in Spain: EPISER2016 study

    Reumatologia Clinica, Vol. 17, Núm. 8, pp. 461-470

2020

  1. Association between periodontitis and anti-citrullinated protein antibodies in rheumatoid arthritis patients: A cross-sectional study

    Arthritis Research and Therapy, Vol. 22, Núm. 1

  2. Prevalence of Sjögren’s syndrome in the general adult population in Spain: estimating the proportion of undiagnosed cases

    Scientific Reports, Vol. 10, Núm. 1

  3. Prevalence of systemic lupus erythematosus in Spain: Higher than previously reported in other countries?

    Rheumatology (United Kingdom), Vol. 59, Núm. 9, pp. 2556-2562

2019

  1. Objectives and methodology of BIOBADASER phase III

    Reumatologia Clinica, Vol. 15, Núm. 4, pp. 229-236

  2. Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): Aims and methodology

    Reumatologia Clinica, Vol. 15, Núm. 2, pp. 90-96

2017

  1. Estudio EPISER 2016. El porqué de un nuevo estudio epidemiológico

    Reumatologia Clinica, Vol. 13, Núm. 1, pp. 1-3

  2. Isolated Ro52 Antibodies as Immunological Marker of a Mild Phenotype of Undifferentiated Connective Tissue Diseases

    International Journal of Rheumatology, Vol. 2017

  3. Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project

    Journal of Clinical Lipidology, Vol. 11, Núm. 3, pp. 749-756.e3

2015

  1. Differential antigen-presenting B cell phenotypes from synovial microenvironment of patients with rheumatoid and psoriatic arthritis

    Journal of Rheumatology, Vol. 42, Núm. 10, pp. 1825-1834

  2. Erratum to "Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project" [Semin Arthritis Rheum 44 (2015) 618-626]

    Seminars in Arthritis and Rheumatism